References
1. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996;94(12):3246-50.
2. Klepac P, Locatelli I, Korosec S, Kunzli N, Kukec A. Ambient air pollution and pregnancy outcomes: A comprehensive review and identification of environmental public health challenges. Environ Res. 2018;167:144-59.
3. Clemens T, Turner S, Dibben C. Maternal exposure to ambient air pollution and fetal growth in North-East Scotland: A population-based study using routine ultrasound scans. Environ Int. 2017;107:216-26.
4. Aguilera I, Garcia-Esteban R, Iniguez C, Nieuwenhuijsen MJ, Rodriguez A, Paez M, et al. Prenatal exposure to traffic-related air pollution and ultrasound measures of fetal growth in the INMA Sabadell cohort. Environ Health Perspect. 2010;118(5):705-11.
5. Carvalho MA, Bernardes LS, Hettfleisch K, Pastro LD, Vieira SE, Saldiva SR, et al. Associations of maternal personal exposure to air pollution on fetal weight and fetoplacental Doppler: A prospective cohort study. Reprod Toxicol. 2016;62:9-17.
6. Hansen CA, Barnett AG, Pritchard G. The effect of ambient air pollution during early pregnancy on fetal ultrasonic measurements during mid-pregnancy. Environ Health Perspect. 2008;116(3):362-9.
7. Iniguez C, Ballester F, Estarlich M, Esplugues A, Murcia M, Llop S, et al. Prenatal exposure to traffic-related air pollution and fetal growth in a cohort of pregnant women. Occup Environ Med. 2012;69(10):736-44.
8. Malmqvist E, Liew Z, Kallen K, Rignell-Hydbom A, Rittner R, Rylander L, et al. Fetal growth and air pollution - A study on ultrasound and birth measures. Environ Res. 2017;152:73-80.
9. Ritz B, Qiu J, Lee PC, Lurmann F, Penfold B, Erin Weiss R, et al. Prenatal air pollution exposure and ultrasound measures of fetal growth in Los Angeles, California. Environ Res. 2014;130:7-13.
10. van den Hooven EH, Pierik FH, de Kluizenaar Y, Hofman A, van Ratingen SW, Zandveld PY, et al. Air pollution exposure and markers of placental growth and function: the generation R study. Environ Health Perspect. 2012;120(12):1753-9.
11. Dibben C, Clemens T. Place of work and residential exposure to ambient air pollution and birth outcomes in Scotland, using geographically fine pollution climate mapping estimates. Environ Res. 2015;140:535-41.
12. Hjortebjerg D, Andersen AM, Ketzel M, Pedersen M, Raaschou-Nielsen O, Sorensen M. Associations between maternal exposure to air pollution and traffic noise and newborn’s size at birth: A cohort study. Environ Int. 2016;95:1-7.
13. Malley CS, Kuylenstierna JC, Vallack HW, Henze DK, Blencowe H, Ashmore MR. Preterm birth associated with maternal fine particulate matter exposure: A global, regional and national assessment. Environ Int. 2017;101:173-82.
14. Pedersen M, Giorgis-Allemand L, Bernard C, Aguilera I, Andersen AM, Ballester F, et al. Ambient air pollution and low birthweight: a European cohort study (ESCAPE). Lancet Respir Med. 2013;1(9):695-704.
15. Rich DQ, Liu K, Zhang J, Thurston SW, Stevens TP, Pan Y, et al. Differences in Birth Weight Associated with the 2008 Beijing Olympics Air Pollution Reduction: Results from a Natural Experiment. Environ Health Perspect. 2015;123(9):880-7.
16. Stieb DM, Chen L, Hystad P, Beckerman BS, Jerrett M, Tjepkema M, et al. A national study of the association between traffic-related air pollution and adverse pregnancy outcomes in Canada, 1999-2008. Environ Res. 2016;148:513-26.
17. Stieb DM, Chen L, Beckerman BS, Jerrett M, Crouse DL, Omariba DW, et al. Associations of Pregnancy Outcomes and PM2.5 in a National Canadian Study. Environ Health Perspect. 2016;124(2):243-9.
18. Shi W, Swan KF, Lear SR, O’Neil JS, Erickson SK, Henson MC. Regulation of pathways determining cholesterol availability in the baboon placenta with advancing gestation. Biol Reprod. 1999;61(6):1499-505.
19. Stefulj J, Panzenboeck U, Becker T, Hirschmugl B, Schweinzer C, Lang I, et al. Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res. 2009;104(5):600-8.
20. Macchi C, Ferri N, Favero C, Cantone L, Vigna L, Pesatori AC, et al. Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals. Eur J Prev Cardiol. 2019;26(6):578-88.
21. Adorni MP, Ruscica M, Ferri N, Bernini F, Zimetti F. Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer’s Disease. Front Aging Neurosci. 2019;11:120.
22. An D, Wei X, Li H, Gu H, Huang T, Zhao G, et al. Identification of PCSK9 as a novel serum biomarker for the prenatal diagnosis of neural tube defects using iTRAQ quantitative proteomics. Sci Rep. 2015;5:17559.
23. Apaijai N, Moisescu DM, Palee S, McSweeney CM, Saiyasit N, Maneechote C, et al. Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation. J Am Heart Assoc. 2019;8(2):e010838.
24. Dias MAB, De Oliveira L, Jeyabalan A, Payne B, Redman CW, Magee L, et al. PREPARE: protocol for a stepped wedge trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia. BMC Pregnancy Childbirth. 2019;19(1):343.
25. Ruscica M, Simonelli S, Botta M, Ossoli A, Lupo MG, Magni P, et al. Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(9):991-7.
26. Silibello C, Calori G, Brusasca G, +., Giudici A, Angelino E, Fossati G, et al. Modelling of PM10 concentrations over Milano urban area
using two aerosol modules. Environ Model Software. 2008;23(3):11.
27. Ruscica M, Ferri N, Fogacci F, Rosticci M, Botta M, Marchiano S, et al. Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study. J Am Heart Assoc. 2017;6(5).
28. Ridker PM, Rifai N, Bradwin G, Rose L. Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events. Eur Heart J. 2016;37(6):554-60.
29. Pecks U, Rath W, Maass N, Berger B, Lueg I, Farrokh A, et al. Fetal gender and gestational age differentially affect PCSK9 levels in intrauterine growth restriction. Lipids Health Dis. 2016;15(1):193.
30. Dube E, Ethier-Chiasson M, Lafond J. Modulation of cholesterol transport by insulin-treated gestational diabetes mellitus in human full-term placenta. Biol Reprod. 2013;88(1):16.
31. Heitritter SM, Solomon CG, Mitchell GF, Skali-Ounis N, Seely EW. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab. 2005;90(7):3983-8.
32. Lee PC, Talbott EO, Roberts JM, Catov JM, Sharma RK, Ritz B. Particulate air pollution exposure and C-reactive protein during early pregnancy. Epidemiology. 2011;22(4):524-31.
33. Schins RP, Lightbody JH, Borm PJ, Shi T, Donaldson K, Stone V. Inflammatory effects of coarse and fine particulate matter in relation to chemical and biological constituents. Toxicol Appl Pharmacol. 2004;195(1):1-11.
34. Adank MC, Benschop L, Peterbroers KR, Smak Gregoor AM, Kors AW, Mulder MT, et al. Is maternal lipid profile in early pregnancy associated with pregnancy complications and blood pressure in pregnancy and long term postpartum? Am J Obstet Gynecol. 2019;221(2):150 e1- e13.
35. B HAW, Dodds J, Placzek A, Beresford L, Spyreli E, Moore A, et al. Mediterranean-style diet in pregnant women with metabolic risk factors (ESTEEM): A pragmatic multicentre randomised trial. PLoS Med. 2019;16(7):e1002857.
36. Berkane N, Liere P, Oudinet JP, Hertig A, Lefevre G, Pluchino N, et al. From Pregnancy to Preeclampsia: A Key Role for Estrogens. Endocr Rev. 2017;38(2):123-44.
37. Lakoski SG, Lagace TA, Cohen JC, Horton JD, Hobbs HH. Genetic and metabolic determinants of plasma PCSK9 levels. J Clin Endocrinol Metab. 2009;94(7):2537-43.
38. Ooi TC, Raymond A, Cousins M, Favreau C, Taljaard M, Gavin C, et al. Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humans. Clin Chim Acta. 2015;446:97-104.
39. Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci U S A. 2003;100(3):928-33.
40. Botha TC, Pilcher GJ, Wolmarans K, Blom DJ, Raal FJ. Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies. Atherosclerosis. 2018;277:502-7.
41. Ward NC, Page MM, Watts GF. Clinical guidance on the contemporary use of proprotein convertase subtilisin/kexin type 9 monoclonal antibodies. Diabetes Obes Metab. 2019;21 Suppl 1:52-62.
42. Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, et al. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. J Clin Lipidol. 2014;8(2):148-72.
43. Lim CC, Mahmood T. Obesity in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015;29(3):309-19.
44. Hauspurg A, Parry S, Mercer BM, Grobman W, Hatfield T, Silver RM, et al. Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women. Am J Obstet Gynecol. 2019;221(3):277 e1- e8.
45. Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart. 2019;105(16):1273-8.
46. Sun M, Yan W, Fang K, Chen D, Liu J, Chen Y, et al. The correlation between PM2.5 exposure and hypertensive disorders in pregnancy: A Meta-analysis. Sci Total Environ. 2019;703:134985.
47. Jasper R, Skelding K. Cardiovascular disease risk unmasked by pregnancy complications. Eur J Intern Med. 2018;57:1-6.
48. Cicoira M. Ambient air pollution as a new risk factor for cardiovascular diseases: Time to take action. Eur J Prev Cardiol. 2018;25(8):816-7.
49. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, et al. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 2004;109(21):2655-71.
50. Yang BY, Guo Y, Morawska L, Bloom MS, Markevych I, Heinrich J, et al. Ambient PM1 air pollution and cardiovascular disease prevalence: Insights from the 33 Communities Chinese Health Study. Environ Int. 2019;123:310-7.